VDDB: a comprehensive resource and machine learning platform for antiviral drug discovery

  title={VDDB: a comprehensive resource and machine learning platform for antiviral drug discovery},
  author={Shunming Tao and Yihao Chen and Jingxing Wu and Duancheng Zhao and Hanxuan Cai and Ling Wang},
Virus infection is one of the major diseases that seriously threaten human health. To meet the growing demand for mining and sharing data resources related to antiviral drugs and to accelerate the design and discovery of new antiviral drugs, we presented an open-access antiviral drug resource and machine learning platform (VDDB), which, to the best of our knowledge, is the first comprehensive dedicated resource for experimentally verified potential drugs/molecules based on manually curated data… 

Figures and Tables from this paper



DrugRepV: a compendium of repurposed drugs and chemicals targeting epidemic and pandemic viruses

The information of repurposed drugs tested for antiviral activity from literature is presented in the form of a user-friendly web server named 'DrugRepV', which contains 8485 entries with biological, chemical, clinical and structural information of 23 viruses responsible to cause epidemics/pandemics.

AVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses

AVPdb is developed to provide a dedicated resource of experimentally verified AVPs targeting over 60 medically important viruses including Influenza, HCV, HSV, RSV, HBV, DENV, SARS, etc, and separately provided HIV inhibiting peptides in ‘HIPdb’.

HDAC3i‐Finder: A Machine Learning‐based Computational Tool to Screen for HDAC3 Inhibitors

This work compiled a set of 1098 compounds from the ChEMBL database that have been assayed against HDAC3 and calculated three different sets of molecular features for each compound and generated 15 models, among which the best‐performing one was the XGBoost model based on the Morgan2 fingerprints, which achieved a high early ROC enrichment.

VIOLIN: vaccine investigation and online information network

The vaccine investigation and online information network (VIOLIN) is a web-based central resource, allowing easy curation, comparison and analysis of vaccine-related research data across various human pathogens and across humans, other natural hosts and laboratory animals.

A comprehensive map of molecular drug targets

An updated comprehensive map of molecular targets of approved drugs is presented and the relationships between bioactivity class and clinical success, as well as the presence of orthologues between human and animal models and between pathogen and human genomes are explored.

Using reverse docking for target identification and its applications for drug discovery

In this review, the authors examine how reverse docking methods have evolved over the past fifteen years and how they have been used for target identification and related applications for drug discovery.

CoV-AbDab: the Coronavirus Antibody Database

This database is the first consolidation of antibodies known to bind Sars-CoV-2 and other betacoronaviruses such as SARS- coV-1 and MERS-Cov and exemplifies a spectrum of potential applications for the database, including identifying characteristic germline usage biases in receptor-binding domain antibodies.

admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties

An ADMET structure-activity relationship database that collects, curates, and manages available ADMET-associated properties data from the published literature, and provides a user-friendly interface to query a specific chemical profile, using either CAS registry number, common name, or structure similarity.

Discovering New Agents Active against Methicillin-Resistant Staphylococcus aureus with Ligand-Based Approaches

To discover new agents active against methicillin-resistant Staphylococcus aureus (MRSA), in silico models derived from 5451 cell-based anti-MRSA assay data were developed using four machine learning

Chemical fragment-based CDK4/6 inhibitors prediction and web server

In silico model-derived CDK4 assay data can predict CDK6 inhibitors (overall predictive accuracies of ∼70–86%).